A multi-gene test that forecasts if preliminary staging breast cancer patients would be benefitted due to chemotherapy is majorly impacting treatment verdicts taken by both the patient and physicians comparably. The multi-gene test known as Oncotype DX manufactured by Genomic Health Industries lead to doctors changing their treatment suggestions in about thirty-two percent of the cases whereas twenty-seven percent of the patients modified their treatment choices. In majority of these cases, the amendment in decision was observed from both the doctors as well as the patient’s end to steer clear from undergoing chemotherapy. The Oncotype DX multi-gene test evaluates twenty-one genes from a neoplasm sample for ascertaining how progressive the neoplasms were. An analysis score lying from zero  [...]

According to an in-progress study presented during the yearly congregation of the Radiological Society of North America (RSNA) showed that elastography is an effectual, expedient system that when included to breast ultrasound aids in detection of cancerous breast lesions from benign outcomes. When the outcome of mammography gives dubious findings, doctors mostly employ ultrasound to attain added information. On the other hand ultrasound has the possibility to lead to additional biopsies due to its comparatively squat specificity or incapability to precisely differentiate cancerous lesions from benign lesions. According to the American Cancer Society about eighty percent of breast lesions that underwent biopsies turned out to be benign in nature. Stamatia V. Destounis, M.D., the lead author  [...]

Scientists from Clemson University in association with scientists from the University of Bremen, Germany are working in unison to allay the physical discomforting sensation undergone during mammograms a matter of the past, and allowing for investigative imaging to be ultimately carried out in a house setting. The group of scientists are aiming at refining DOT or Diffuse Optical Tomography for creating enhanced resolution imagery from a diffusion of infrared and detectable light for the early diagnosis of breast cancer. The procedure is cost-effective, has a higher safety quotient and less levels of discomfort associated with it in comparison to the X-rays that have been employed during mammograms. The issue with X-rays is producing an effective resolution for detecting smaller breast cancers. The  [...]

There have been growing fears about mastectomy being overly employed as a treatment option for breast cancer. A study conducted that was printed in the 14th October edition of JAMA, carried out an analysis of about two thousand women suggested that breast-conservation surgery was undertaken as the initial treatment in nearly 75% of those analysed. Monica Morrow, M.D., from the Memorial Sloan-Kettering Cancer Center, New York did the presentation of the study findings at the JAMA media update in Chicago. She stated that the rising worries of mastectomy being used on patients having breast cancer have increased in past twenty years. BCS or breast conservation surgery has been employed by few as a quality measure. In spite of a noticeable rise in BCS, fears continue about the overtreatment with  [...]

At the conclusion of the decade old, coast-to-coast survey on women having a rare type of breast cancer, Richard J. Barth Jr., M.D., and three associate researchers are composing the case for a particular blend of treatments for halting the tumors prior to metastasis. In the Aug-09 edition of the Annals of Surgical Oncology, Barth, an associate professor of surgery at Dartmouth Medical School (DMS) and his associates along with Wendy Wells, M.D. – a professor of pathology in DMS suggest employing adjunct radiotherapy on those patients that underwent breast-preservation surgery for controlling borderline malignant and malignant phyllodes tumors. The follow-ups done on the improvement in 46 women that were given follow-up radiotherapy in thirty diverse organizations in eighteen states, the  [...]

A potent new-fangled breast cancer treatment could be the upshot due to binding one of the novel drugs that hamper cancer’s characteristic uninhibited proliferation with another that obstructs a primal survival method wherein the cancer cells gobble up sections of themselves. During the Molecular Targets and Cancer Therapeutics International Conference, Boston, the researchers from Medical College of Georgia Cancer Center reported that while they are potent obliterators of some breast cancer cells, novel drugs known as histone deacetylase inhibitors (HDAC inhibitors), additionally augment self-assimilation or autophagy, in enduring, mega-strained cells. Dr. Kapil Bhalla, Director of the MCG Cancer Center stated that for meeting the energy requirements of proliferation and survival, cancer  [...]

The present year has been impressive in regards to breast cancer research. Several researches being conducted would aid in averting, detecting and treating this disease which is much dreaded in women. Amongst the most significant ones are stated below: Sanguinity in difficult cases Comparatively lesser number of drugs have been observed to effectively combat against the ‘triple negative’ breast cancer – Receptors for estrogen, progesterone and HER2 are scarce in these tumors. However, a novel class of drug known as PARP inhibitors could bring out a major transformation. During a study conducted on patients having advanced stages of breast cancer, when PARP inhibitor was administered alongside chemotherapy, the survival time among these patients rose by fifty percent – a remarkable  [...]

A novel headway was made in Breast Cancer Treatment with the finding of trial agent that lowers breast cancer metastasis to the Bone. Scientists have employed a trial agent for inhibiting ROCK – a protein observed to be in an over-expressed state in metastasized breast cancer. The study conducted on mice by the able team of researchers hailing from the Tufts University of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center reported that hindering ROCK (Rho-associated kinase) in the preliminary stages of breast cancer lowered metastatic tumor mass in the bone by seventy-seven percent and occurrence of metastasis on the whole by thirty-seven percent. The outcome points to the fact that ROCK could be targeted for novel drug treatments for lowering  [...]

Visualize one going in for a routine mammogram and are gladly informed by the doctor that one does not have breast cancer. However, the ‘catch-22’ situation occurs when the doctor then informs that one is having a major risk factor for the invasive form of cancer known as DCIS or ductal carcinoma in situ, at times also known as ‘stage zero’ cancer. DCIS is a condition wherein the anomalous cells have laid siege in one or more ducts in the breasts – the conduits that connect the milk-secreting lobes to the nipples. This means that the anomalous cells have not yet spread to the other breast tissues. The likelihood of them spreading or not, is still quite unclear. Hence, when one is faced with such tricky situation, it is no wonder why DCIS detection could lead to major confusion and  [...]